<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR45">
 <label>45.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Qiu</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Jiang</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Gong</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Guo</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>C</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: a randomized controlled non-inferiority clinical trial</article-title>
  <source>Hum Vaccin Immunother</source>
  <year>2017</year>
  <volume>13</volume>
  <issue>6</issue>
  <fpage>1</fpage>
  <lpage>10</lpage>
  <pub-id pub-id-type="doi">10.1080/21645515.2017.1288769</pub-id>
  <?supplied-pmid 28362135?>
  <pub-id pub-id-type="pmid">28362135</pub-id>
 </element-citation>
</ref>
